$CHRS – IPO Boutique

02.07.2017 Secondary Announcement-p.m.

Posted on February 7, 2017

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Coherus Biosciences Symbol: CHRS Price: Last trade $26.65 Description: Re-offer range $24.00-$25.00 Trade Date: 2/8 Shares: 4.7 million Underwriter(s)J.P. Morgan, Citigroup,[…]

Secondaries announced 3.30.2015

Posted on March 30, 2015

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Mylan N.V. Symbol: MYL Price: Last trade $61.63 Trade Date: 4/1 Shares: 35 million Underwriter(s) Morgan Stanley, Goldman Sachs Rating=Subscription Needed[…]